New* VP of Research and Operations...Hmmmmm. We may see changes some here have talked about. IMHFO.
I thought the current data and implications with AGN's limited successes could have been promoted into a possible partnership for Phase 3. A least taking the time to try. Attitude and Presentation are So important for salesmen or Management...
Remdeath and others barely show limited success (with High Safety issues) and yet the CTs that ALL the BigP have had has taken most of the patients trying to show SOME significance. IS there significance or just Masks/SD/SOC effects? Sadly for all infected, all BigP drugs are also with limited results so far. But they HAVE suppressed competition well. No SILVER Bullets.
Glomming most of the World's vaccines here in the USA with 130 countries getting NONE.?. Will the Viruses be tweaked thru Rna mutations? karma? Shots every 6 months?
AGN did well to complete this first Phase. IMO. Yes, Data should be Reviewed and as much data as possible collected / presented (Xrays). Can we see a PowerPoint and some Graphs. Something MORE than a 'finger wave'!
A strong effort to highlight the benefits of Ifenprodil, FROM MANAGEMTNT, is needed by shareholders. Glum moping and unprepared blow-offs of KEY questions wont help the PPS. Statements like 'WE WILL WORK HARD TOWARDS OUR GOALS' are needed. Not 'oh well', 'I dont think we can do that' and 'BS technicality Duhs'. IMHFO.
Opinions that are possible excuses should be kept buried and NOT be the main topics left for message-Boards and investors to consider.
ICU time Maters, Fibrosis Maters and EVERY EFFORT should be made to Highlight successes and correlate them and SHOW Progress. It's THERE...JMHFO...GLTA...
*Dud
